Spanish biotech company Puleva Biotech will later this week ask shareholders to approve its proposal to issue 1.7 million new shares at €0.6 (US$0.52) apiece.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The company will boost the startup’s capital by some €20.5m. Puleva Biotech, which spun off from food giant Puleva, was listed on Spain’s high-tech Nuevo Mercado market last December, and sought the issue as part of an employee loyalty plan.
The firm has registered a patent for a naturally based product to reduce cholesterol levels, reported El Pais.
